Prenatal Maternal Depression and Neonatal Immune Responses

Area of Science:

• Immunology
• Developmental Psychology
• Perinatal Health

Background:

• Maternal depression is a significant public health concern.
• Early life immune system development is crucial for long-term health.
• The impact of maternal depression on infant immune regulation is not fully understood.

Purpose of the Study:

• To investigate the association between lifetime maternal depression and infant immune responses at birth.
• To analyze cord blood cytokine levels and lymphocyte proliferation (LP) in relation to maternal depression history.

Main Methods:

• Longitudinal cohort study (Project Viva) with 463 mother-infant pairs.
• Maternal depressive symptoms assessed using the Edinburgh Postnatal Depression Scale and questionnaires.
• Cord blood mononuclear cells analyzed for cytokine concentrations (IL-6, IL-10, IL-13, TNF-α, IFN-γ) and LP after stimulation.

Main Results:

• Infants born to mothers with a history of depression showed significantly lower levels of interleukin-10 (IL-10) when cord blood cells were stimulated with allergens (cockroach, house dust mite) or phytohemagglutinin (PHA).
• Specific reductions in IL-10 were observed: -41.4% (p = .027) for cockroach extract, -36.0% (p = .071) for house dust mite extract, and -24.2% (p = .333) for PHA.
• No significant differences were found in other measured cytokines or lymphocyte proliferation (LP).

Conclusions:

• Maternal depression is associated with altered offspring immune responses at birth.
• Reduced IL-10 levels in infants of depressed mothers may have implications for future atopic risk and immune function.
• Further research is warranted to explore the long-term consequences of these immune alterations.